Summit Therapeutic SMMT 深 沪
等待开盘 11-18 09:30:00 美东时间
17.075
-0.955
-5.30%
华盛通- 最 高17.99
- 今 开17.77
- 成交量 179.19万股
- 最 低 17.06
- 昨 收 18.03
- 总市值 126.87亿
- 52周最高 36.91
- 市盈率 静 --
- 换手率 0.24%
- 52周最低 15.55
- 委 比 71.01%
- 总股本 7.43亿
- 历史最高 36.91
- 量 比 0.97
- 振 幅 5.16%
- 历史最低 0.66
- 每 手 1
- 风险率 3.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Summit Therapeutics Partner Akeso Publishes Results From Phase III HARMONi-A Trial Showing Statistically Significant OS Benefit
The First Phase III Study Testing Ivonescimab Now Represents the First Statistically Significant OS Benefit Achieved by an Ivonescimab-Containing RegimenIvonescimab Plus Chemotherapy Demonstrates Median OS of 16.8 Months
11-07 22:10
美股夜盘 | Affirm涨10.73%，Innodata涨7.91%
Affirm涨10.73%；Innodata涨7.91%；PMGC Holdings Inc.涨4.06%
11-07 10:02
10.24商业观察：创新药出海龙头股汇总（附股）
（来源：华彬金融观察） 创新药再迎重磅利好催化。 信达生物宣布与武田制药达成全球战略合作，共同推进新一代免疫肿瘤（IO）及抗体药物偶联物（ADC）疗法开发，合作...
10-24 06:02
美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
Summit Therapeutics Raises $500M in Private Placement
Summit Therapeutics ( ($SMMT) ) just unveiled an update. On October 21, 2025, S...
10-22 21:19
Guggenheim Reiterates Buy on Summit Therapeutics, Maintains $40 Price Target
Guggenheim analyst Brad Canino reiterates Summit Therapeutics (NASDAQ:SMMT) with a Buy and maintains $40 price target.
10-22 21:14
Summit Therapeutics raises $500M in private placement
Summit Therapeutics (NASDAQ:SMMT) said on Wednesday that it has accepted offers from multiple leading biotech institutional and individual investors to purchase an aggregate of approximately 26.68M s...
10-22 20:15
Tesla recalls select Model 3, Ys over battery connection failure
Tesla (NASDAQ:TSLA) is recalling select 2025 Model 3 and 2026 Model Y vehicles due to a potential battery pack contactor failure that could result in a loss of drive power, the Affected vehicles are e...
10-22 15:44
